Skip to cookie consent Skip to main content

Funding programs for innovators

Lab eN2

Lab eN2 is a drug discovery collaboration between Novo Nordisk, Evotec, and several academic institutions.

The indications of interest are chronic diseases in the cardiometabolic space, with an openness to explore any modality.

Projects are selected on a rolling basis, with the first step being an internal discussion followed by a non-confidential call with the scientific liaison from Evotec.


Mark Fulton, PhD
Alliance Manager

Please reach out to your Licensing Manager or Mark Fulton for specific areas of interest and more information.